IL299028A - Methods and preparations for the treatment of induced diarrhea - chemotherapy - Google Patents

Methods and preparations for the treatment of induced diarrhea - chemotherapy

Info

Publication number
IL299028A
IL299028A IL299028A IL29902822A IL299028A IL 299028 A IL299028 A IL 299028A IL 299028 A IL299028 A IL 299028A IL 29902822 A IL29902822 A IL 29902822A IL 299028 A IL299028 A IL 299028A
Authority
IL
Israel
Prior art keywords
composition
crofelemer
cancer
subject
chemotherapy
Prior art date
Application number
IL299028A
Other languages
English (en)
Hebrew (he)
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of IL299028A publication Critical patent/IL299028A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL299028A 2020-06-19 2020-06-19 Methods and preparations for the treatment of induced diarrhea - chemotherapy IL299028A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2020/038691 WO2021257089A1 (en) 2020-06-19 2020-06-19 Methods and compositions for treating chemotherapy-induced diarrhea

Publications (1)

Publication Number Publication Date
IL299028A true IL299028A (en) 2023-02-01

Family

ID=79268234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL299028A IL299028A (en) 2020-06-19 2020-06-19 Methods and preparations for the treatment of induced diarrhea - chemotherapy

Country Status (10)

Country Link
EP (1) EP4168027A4 (de)
JP (1) JP2023538186A (de)
KR (1) KR20230027226A (de)
AU (1) AU2020454132A1 (de)
BR (1) BR112022025741A2 (de)
CA (1) CA3182864A1 (de)
IL (1) IL299028A (de)
JO (1) JOP20220339A1 (de)
MX (1) MX2022016367A (de)
WO (1) WO2021257089A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115089592B (zh) * 2022-05-21 2024-02-27 复旦大学 多重酪氨酸激酶在制备抑制肠道病毒71型嗜神经性病毒药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011044167A1 (en) * 2009-10-06 2011-04-14 University Of California, San Francisco Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CA2816416C (en) * 2010-10-31 2020-02-11 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
US20160067311A1 (en) * 2014-09-10 2016-03-10 Helsinn Healthcare Sa Use of elsiglutide to treat gastrointestinal mucositis including chemotherapy-induced diarrhea
CA2972996A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
CA3046207A1 (en) * 2016-12-06 2018-06-14 Kaleido Biosciences, Inc. Glycan polymers and related methods thereof

Also Published As

Publication number Publication date
EP4168027A1 (de) 2023-04-26
WO2021257089A1 (en) 2021-12-23
MX2022016367A (es) 2023-01-30
JP2023538186A (ja) 2023-09-07
CA3182864A1 (en) 2021-12-23
JOP20220339A1 (ar) 2023-01-30
EP4168027A4 (de) 2024-04-03
AU2020454132A1 (en) 2023-02-02
KR20230027226A (ko) 2023-02-27
BR112022025741A2 (pt) 2023-01-03

Similar Documents

Publication Publication Date Title
US20210100813A1 (en) Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
AU2013203637B2 (en) Combination therapy for proliferative disorders
RU2747788C2 (ru) Комбинированная терапия ингибиторами notch и cdk4/6 для лечения рака
JP6706255B2 (ja) 放射線、酸化セリウムナノ粒子、及び化学療法剤の併用によるがんの治療
RU2717570C2 (ru) Синергистические комбинации ауристана
RU2754452C2 (ru) Комбинированная терапия ингибиторами notch и pi3k/mtor для применения в лечении рака
CN111527103A (zh) 用于治疗或预防her驱动的抗药性癌症的化合物、组合物和方法
MX2013013018A (es) Metodo para el tratamiento oncologico combinado dirigido a egfr.
KR101475167B1 (ko) 복합 항암 요법
CN110730663B (zh) 阿帕替尼和c-Met抑制剂联合在制备治疗肿瘤的药物中的用途
AU2017268187A1 (en) Combination therapy with notch and PD-1 or PD-L1 inhibitors
WO2022111714A1 (zh) 用于治疗pik3ca突变癌症的组合疗法
CA2807218A1 (en) Novel combination therapy for the treatment of cancer
CN111629718A (zh) 对癌症患者的治疗有用的尿碱剂
WO2022271964A1 (en) Erk1/2 and shp2 inhibitors combination therapy
IL299028A (en) Methods and preparations for the treatment of induced diarrhea - chemotherapy
WO2021104487A1 (en) Composition including rilpivirine and use thereof for treating tumors or cancer
TWI598095B (zh) 治療或緩解高齡或末期癌症患者用之醫藥組合物
EP1729807A2 (de) Kombinationstherapie
CN115624552A (zh) 用于乳腺癌的辅助治疗的内分泌疗法和abemaciclib组合
JP4091639B2 (ja) チロシンキナーゼ阻害剤が惹起する皮膚障害の予防剤および／または処置剤
Booth et al. Non-surgical Cancer Treatments
JP4322933B2 (ja) チロシンキナーゼ阻害剤が惹起する皮膚障害の予防剤および／または処置剤
WO2023011415A1 (zh) Egfr抑制剂的药物组合及其应用
Fitzgerald et al. Targeted agents in cancer